CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
Fitbit Zip +4 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03022032
NCT03022032N/ACompleted
CompareCT.gov

The HOPE Trial: Helping Our Patients Excel, and The SMART Study: Symptom Management and Reporting

Dana-Farber Cancer Institute·interventional·Posted Jan 16, 2017·Updated Sep 9, 2025

In Brief

A clinical study evaluating Fitbit Zip, HOPE App, and 3 other interventions for Gynecologic Cancer. Completed, enrolled 102 participants across 1 site.

Detailed Summary

This research study is evaluating a new smartphone application named the "Helping Our Patients Excel (HOPE)" app with a Fitbit device. The SMART Study is a sub-study of the HOPE Trial. Both studies evaluate an almost identical intervention using a Fitbit device and smartphone app(s) with the goal of improving quality-of-life for women with gynecologic cancers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGynecologic Cancer
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 16, 2017
Enrollment StartApr 12, 2017
Primary CompletionSep 2, 2020
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 9.5 years ago

Interventions

Fitbit Zipdevice

Fitbit Zip

HOPE Appother

HOPE App

Standard of Careother

Standard of Care

Fitbit Charge 2device

Fitbit Charge 2

SMART Study Interventionother

SMART study app + Beiwe study app + Fitbit